Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: FCA, bank competition, Glaxo

Sun, 30th Mar 2014 16:53

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write to Chancellor George Osborne to complain about the FCA. Senior sources at four of Britain's biggest insurers told the paper Wheatley's position was untenable.Andrew Tyrie, Chairman of the Treasury Select Committee, has accused the Financial Conduct Authority of an "extraordinary blunder" in announcing market sensitive information about the insurance sector, the Sunday Telegraph reported. Insurer shares fell heavily on Friday after FCA Director of Supervision Clive Adamson told the Telegraph the watchdog planned an inquiry into pensions dating back to the 1970s. Tyrie said the FCA's pledge to bring in an external law firm to investigate the affair was not enough and that his committee would probably vet the inquiry head.The head of the Competition and Markets Authority (CMA) has said Labour leader Ed Miliband's plan for a swift breakup of Britain's banks is unworkable, the Sunday Telegraph reported. Alex Chisholm, Chief Executive of the new competition regulator, said an investigation would take at least 18 months and that any resulting disposals could take many years. Miliband said in January that a Labour government would introduce a threshold for personal current accounts and business banking and give the CMA six months to set the limit. Chisolm said the CMA, in shadow form, had been looking at small business banking for about six months.GlaxoSmithKline is planning a multimillion-pound investment in sub-Saharan Africa, the Sunday Telegraph reported. The pharmaceutical giant will announce plans to build up to five new factories on March 31st. It is looking at sites in Ghana, Ethiopia and Rwanda. Glaxo thinks Africa will be one of the fastest growing parts of the world over the next 50 years. Sub-Saharan Africa provides about £500m of Glaxo's £26.5bn annual sales.Land Securities has put on hold plans to build 200 luxury flats near Buckingham Palace until after next year's general election, the Sunday Times reported. The decision is the first sign that threats of a "mansion tax" are affecting developers' plans. The industry fears a 1% tax on homes worth more than £2m - a policy picked up by Labour that housebuilders are concerned the Conservatives will emulate.Royal Bank of Scotland is close to appointing Ewen Stevenson, one of the brains behind the 2008 banking bailout, as its new Finance Director, according to the Sunday Times. Stevenson, co-head of European investment banking at Credit Suisse, is said to have dreamt up the asset protection scheme insurance programme that stopped RBS shareholders being entirely wiped out during the financial crisis.A funding crisis has cast doubt on the future of Britain's second-biggest oil refinery, the Sunday Times said. The Stanlow plant is owned by Essar Energy, the Indian power and mining company whose founders are trying to buy it back after listing in London four years ago. Stanlow has to refinance a £330m loan from Barclays in July after using up £173m of its cash in the nine months to December. Essar said Stanlow was within its debt covenants and that the plant had the advantage of producing lots of diesel and jet fuel, of which the UK produces little.Real incomes in the UK are back to pre-financial crisis levels, the Sunday Times said. Figures in the small print of official figures released on March 28th showed real household disposable incomes were £507.7bn in the second half of last year - up 4% from the first half of 2008. Britain's population has risen in that time but by less than incomes. The figures suggest the squeeze on household budgets is easing fast.Card Factory is planning to join the line of retailers floating on the stock market with a share sale that could value the discount group at more than £700m, the Sunday Telegraph said. Its private equity owner, Charterhouse, is working on a flotation for this summer. Card Factory Chief Executive Richard Hayes told the paper he wanted to expand from 700 stores to as many as 1,100.A Chinese tycoon is in talks to buy House of Fraser for more than £450m, the Sunday Times reported. Yuan Yafei's Sanpower conglomerate has been in talks with House of Fraser for several months. The department store group's Chairman Don McCarthy has accepted the bid and has presented it to the company's other main shareholders for approval. The deal would end plans for House of Fraser to join the procession of retail initial public offerings.
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.